I bought 300 shares of Cassava Science at $57, after it dropped by more than 50% from its peak of $122. The drop was caused by some allegation that the data for its clinical trial was flawed.
The price had dropped to $52, giving me a loss of $1,500 USD.
1 comment:
Hi Mr Tan,
Your Links on the right "Prepare your Financial Plan" leads to a Chinese sleazy website.
Post a Comment